Faeth Therapeutics, Inc. (NASDAQ:FTH)
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$211.4M
- Net margin
- —
Little or no net debt.
- Total debt
- $145K
- Cash
- $14.2M
- Debt / equity
- 0.00
Comfortably covers what is due within a year.
- Current assets
- $177.8M
- Current liabilities
- $11.0M
- Current ratio
- 16.12
Consumes cash and must keep raising it.
- Operating cash flow
- -$43.3M
- Free cash flow
- -$43.3M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 25.8M
- Share growth (1y)
- 1948.7%
- Cash runway
- 4 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
FTH Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -4.85 M | 0.00 |
| Revenue Growth (YoY) | 100.00 % | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 132.96 M | 0.00 | -4.85 M | 0.00 |
| Gross Profit | 0.00 | 0.00 | -132.96 M | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 10.35 M | 9.21 M | 19.71 M | 2.79 M | 2.31 M | 2.67 M |
| R&D Expense | 11.74 M | 9.18 M | 17.96 M | 2.17 M | 2.54 M | 2.53 M |
| Operating Expenses | 22.09 M | 18.39 M | 37.67 M | 4.96 M | 4.85 M | 5.21 M |
| Operating Income | -22.09 M | -18.39 M | -170.63 M | -4.96 M | -4.85 M | -5.21 M |
| Pretax Income | -20.40 M | -16.01 M | -170.24 M | -4.72 M | -4.57 M | -4.94 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -20.40 M | -16.01 M | -170.24 M | -4.72 M | -4.57 M | -4.94 M |
| EPS (Basic) | -0.79 | -2.84 | -131.45 | -3.74 | -3.62 | -3.91 |
| EPS (Diluted) | -0.79 | -2.84 | -131.45 | -3.74 | -3.62 | -3.91 |
| Shares Outstanding | 25.84 M | 5.64 M | 1.30 M | 1.26 M | 1.26 M | 1.26 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.